Advanced Glycation End Products And EsRAGE Are Associated With Bone Turnover And Incidence Of Hip Fracture In Older Men

This study examined the relationship between blood sugar damage and bone health in older men. Researchers looked at 3,384 community-dwelling men aged 70-89 years to understand how advanced glycation end products (AGEs) - harmful compounds formed when blood sugar attaches to proteins - might affect bone strength and fracture risk. AGEs are known to accumulate with aging and diabetes, potentially damaging various tissues throughout the body.

The scientists measured several markers in the blood, including compounds that form when sugar damages proteins (like CML, methylglyoxal, and glyoxal) and a protective substance called esRAGE that helps clear these harmful compounds. They also measured markers that indicate how actively the body is breaking down and rebuilding bone tissue. Over the follow-up period, 106 men experienced hip fractures.

Surprisingly, the results were more complex than expected. Men with moderate levels of CML (one type of sugar-damage compound) actually had about half the risk of hip fracture compared to those with the lowest levels. Additionally, higher levels of esRAGE - the protective compound - were associated with increased bone formation activity, suggesting the body's repair mechanisms were more active.

These findings suggest that the relationship between blood sugar, aging, and bone health is nuanced. While we typically think of sugar-related damage as harmful, moderate levels of certain compounds might trigger protective responses. For patients focused on metabolic health and longevity, this research highlights the importance of balanced blood sugar management and comprehensive bone health assessment, especially as we age. Healthcare providers may use these insights to better evaluate fracture risk beyond traditional bone density measurements.